63
Participants
Start Date
August 12, 2014
Primary Completion Date
October 4, 2016
Study Completion Date
March 16, 2017
Copanlisib (BAY80-6946)
0.8 mg/kg body weight and 0.4 mg/kg (not to exceed 65 mg) for the non-diabetic patients;45 mg and 60 mg for the diabetic patients; Intravenous (IV) infusion over 1 hour. Dosing of copanlisib will be on Days 1, 8, and 15 of each 28 day treatment cycle.
Bruxelles - Brussel
Bruxelles - Brussel
Ghent
Caen
Lille
Pierre-Bénite
Nice
Sutton
London
Lead Sponsor
Bayer
INDUSTRY